Innovative cardioplegic solutions in cardiovascular surgery
Swiss Cardio Technologies AG, part of the Abacus Medicine Group, is a spin-off from the University of Berne, Switzerland and was founded by a group of cardiovascular surgery specialists in 2008.
Our product
Since its founding, Swiss Cardio Technologies has focused on advancing Cardioplexol®, a cardioplegic solution approved in 10 EU countries and Switzerland. Swiss Cardio Technologies is the exclusive global license holder of Cardioplexol®.
Cardioplexol® is marketed by:
Steckackerstrasse 1,
4132 Muttenz,
Switzerland
For side effect reports:
For product enquiries:
Unit 15, Daingean Hall N4
Axis Centre Longford,
N39 W6K0 Ireland
For side effect reports:
For product enquiries:
Our Team
We are an experienced team of medical professionals, industrial pharmacists and business management.
Farid Taha
Marc Fröhlich
Dr. Erich Gygax
Dr. Andreas Brutsche
Dr. Neil Judge
Dr. Tristan Hollyer
Avni Sharma
Claus Andersen
Governing Board
Strategic lead, control and advisory body of experienced executives and experts that support management in long-term strategic decisions, market opportunities, innovation initiatives, and risk assessment.
Rudolf Tschopp
Dr. Jörg Schulze
Farid Taha
Dr. John Fröhlich
Daniel Niehus
Prof. Dr. med. Dr. h.c. Thierry Carrel
